IC50

From Wikipedia, the free encyclopedia

The correct title of this article is IC50. It features superscript or subscript characters that are substituted or omitted because of technical limitations.

IC50 is a measure of concentration used in pharmacological research. IC50, or the half maximal inhibitory concentration, represents the concentration of an inhibitor that is required for 50% inhibition of its target (i.e. an enzyme, cell, cell receptor or a microorganism). In simpler terms, it measures how much of a particular substance/molecule is needed to inhibit some biological process by 50%.

IC50 is commonly used as a measure of drug effectiveness. Another measure of drug efficacy is EC50 which represents the concentration of a compound that is required to obtain 50% of the maximum effect in vivo. (Ex. EC100 would be the minimum concentration of a compound to obtain 100% of its effect). For competition binding assays and functional antagonist assays IC50 is the most common summary measure of the dose-response curve. For agonist/stimulator assays the most common summary measure is the EC50. (http://www.ncgc.nih.gov/guidance/section3.html)

According to the FDA, IC50 represents the concentration of a drug that is required for 50% inhibition in vitro whereas EC50 represents the plasma concentration required for obtaining 50% of a maximum effect in vivo.(http://www.fda.gov/ohrms/dockets/ac/00/slides/3621s1d/sld036.htm)

IC50 values are dependent on conditions under which they are measured. For example for enzymes, IC50 value increases as enzyme concentration increases. Furthermore depending on the type of inhibition other factors may influence IC50 value; for ATP dependent enzymes IC50 value has an interdependency with concentration of ATP, especially so if inhibition is all of it competitive.

[edit] External links

[edit] See also